{"company": {"org_id": "T000073937", "org_name_cn": "北京赛升药业股份有限公司", "org_short_name_cn": "赛升药业", "org_name_en": "Beijing Science Sun Pharmaceutical Co.,Ltd.", "org_short_name_en": "Science Sun Pharm", "main_operation_business": "注射针剂的研发、生产及销售。", "operating_scope": "　　原料药、针剂的制造;技术开发、技术转让、技术咨询、技术服务;商业特许经营;投资、投资管理、投资咨询。", "district_encode": "110115", "org_cn_introduction": "北京赛升药业股份有限公司的主营业务是注射针剂的研发、生产及销售。公司的主要产品是免疫系统用药、神经系统用药、心脑血管用药。赛盈®纤溶酶注射液被评选为2023年年度生化生物企业优秀品牌，赛典®单唾液酸四己糖神经节苷脂钠注射液被评为2024年度生化、生物药品优秀品牌。", "legal_representative": "马骉", "general_manager": "马骉", "secretary": "王雪峰", "established_date": 927129600000, "reg_asset": 481666400.0, "staff_num": 513, "telephone": "86-10-67862500", "postcode": "100176", "fax": "86-10-67862501", "email": "ssyyzqb@ssyy.com.cn", "org_website": "www.ssyy.com.cn", "reg_address_cn": "北京市大兴区北京经济技术开发区兴盛街8号", "reg_address_en": null, "office_address_cn": "北京市大兴区北京经济技术开发区兴盛街8号", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1435248000000, "provincial_name": "北京市", "actual_controller": "马骉 (49.51%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "马骉", "executives_nums": 14, "actual_issue_vol": 30000000.0, "issue_price": 38.46, "actual_rc_net_amt": 1080944700.0, "pe_after_issuing": 22.99, "online_success_rate_of_issue": 0.36628586, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}}